Endophytic fungi and their bioactive secondary metabolites in medicinal leguminosae plants: nearly untapped medical resources

FEMS Microbiol Lett. 2022 Jul 28;369(1):fnac052. doi: 10.1093/femsle/fnac052.

Abstract

There are many species of Chinese traditional leguminosae family plants that are well known for their medicinal applications, such as Astragalus membranaceus, Catsia tora, Glycyrrhiza uralensis, Sophora flavescens and Albacia acacia. Their unique bioactive composition and internal phenological environment contribute to the formation of specific and unique endophytic fungal communities, which are important resources for new compounds used in a variety of pharmacological activities. Nonetheless, they have not been systematically studied. In the last decade, nearly 64 genera and thousands of species of endophytic fungi have been discovered from leguminosae plants, as well as 138 secondary metabolites (with 34 new compounds) including flavonoid, alkaloids, phenol, anthraquinone, macrolide, terpenoid, phytohormone and many more. These were shown to have diverse applications and benefits, such as antibacterial, antitumor, antioxidative, immunoregulatory and neuroprotective properties. Here, we provide a summarized overview with the aim of raising awareness of endophytic fungi from medicinal leguminosae plants and providing a comprehensive review of the discoveries of new natural products that may be of medicinal and pharmaceutical importance.

Keywords: Fungal endophyte; medicinal plants; natural product; new resource; pharmacological activity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Products* / metabolism
  • Endophytes / metabolism
  • Fabaceae*
  • Fungi
  • Plants, Medicinal* / microbiology

Substances

  • Biological Products